|
Originally published In Press as doi:10.1074/jbc.M312351200 on December 5, 2003
J. Biol. Chem., Vol. 279, Issue 9, 8149-8158, February 27, 2004
MtmMII-mediated C-Methylation during Biosynthesis of the Antitumor Drug Mithramycin Is Essential for Biological Activity and DNA-Drug Interaction*
David Rodríguez ,
Luis M. Quirós , and
José A. Salas ¶
From the
Departamento de Biologí Funcional, Universidad de Oviedo, 33006 Oviedo and the Instituto Universitario de Oncología del Principado de Asturias (I. U. O. P. A.), Universidad de Oviedo, 33006 Oviedo, Spain
The antitumor drug mithramycin consists of a polyketide chromophore glycosylated with a trisaccharide and a disaccharide. Two post-polyketide methylations take place during mithramycin biosynthesis. One of these methylations has been shown to be very relevant for biological activity, that is the introduction of a methyl group at aromatic C-7. We have purified to 282- fold the MtmMII methyltransferase involved in this reaction. The protein is a monomer, and results from kinetic studies were consistent with a model for the enzyme acting via a compulsory order mechanism. The enzyme showed high substrate specificity and was unable to operate on structurally closely related molecules. Structural predictions suggest that the molecule is integrated by two domains, an essentially all -amino domain and an / -carboxyl domain displaying a variation of a Rossmann-fold containing the cofactor binding site. Although 7-demethyl-mithramycin did not show any biological activity, it was able to reach the nucleus of eukaryotic cells, with subsequent binding to DNA. Mithramycin and 7-demethylmithramycin were able to form similar complexes with Mg2+, although their respective DNA binding isotherms were very different. The dinucleotide binding model fit well the isotherms recorded for both compounds, predicting that the C-7 methyl group was essential for high affinity binding to specific GC and CG sequences. Considering previous structural studies, we propose that this effect is performed by positioning the group in the floor of the minor groove, allowing the interaction with the third sugar moiety of the trisaccharide, D-mycarose, which is involved in sequence selectivity.
Received for publication, November 11, 2003
, and in revised form, December 3, 2003.
* This work was supported by a grant from the Plan Regional de Investigación del Principado de Asturias (GE-MEDO1-05). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed. Tel./Fax: 34-985-103652; E-mail: jasalas{at}correo.uniovi.es.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Bataller, C. Mendez, J. A. Salas, and J. Portugal
Mithramycin SK modulates polyploidy and cell death in colon carcinoma cells
Mol. Cancer Ther.,
September 1, 2008;
7(9):
2988 - 2997.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Barcelo, C. Scotta, M. Ortiz-Lombardia, C. Mendez, J. A. Salas, and J. Portugal
Entropically-driven binding of mithramycin in the minor groove of C/G-rich DNA sequences
Nucleic Acids Res.,
April 1, 2007;
35(7):
2215 - 2226.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|